The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
It is good from the trials. Statistically significant increase in speed of wound healing in EB between Filsuvez (formerly Oleogel) and placebo: https://epidermolysisbullosanews.com/2020/09/23/amryt-plans-regulatory-submissions-for-filsuvez-following-positive-phase-3-data/
It's not so much about pain relief. The main importance of Filsuvez to my mind is that quicker wound healing will help reduce the risk of infection. Those with Dystrophic EB in particular often suffer terrible skin infections because wounds from the blisters can remain open for weeks and become antibiotic resistant over time.
Darktrace are a Premier-Tier exhibitor - alongside the likes of Crowdstrike, Microsoft, AWS - at the prestigious US Gartner Security & Risk Management Summit from tomorrow to the 18th. Great exposure in the US (for anyone who still doesn't realise we're a global company!). As the company are doing offering appointments for one-on-one demonstrations, I'll be surprised if it doesn't bring in more sales/US investment interest.
https://www.gartner.com/en/conferences/na/security-risk-management-us/exhibitors
Just to add... recommend you read the Darktrace blog and cybersecurity magazines to get a better picture of the company, what it does and the competition. A large part of the problem with the UK market `experts' is they don't really even have a basic understanding of the tech. The cybersec market will continue to see big increases in demand as cloud computing and IoT grows. Top level machine-learning AI is necessary to thwart increasingly sophisticated often AI-enhanced attacks and cannot be created overnight.
Sam/Brightworth, I believe PH have an agenda due to their history with Autonomy/ML - I've linked to the Register article previously. Their broker forecast didn't account for several income streams and claimed the tech is easily imitated which is utterly absurd. Jefferies/Berenberg are the house brokers, but even if you take a midway point between the three we're considerably undervalued now.
Some of the steep rise in the SP can be accounted for after the final results RNS which recorded that there was a 45.3% increase in number of customers year-on-year, which upped the future sales forecast. You can also look at DARK's real competition in the likes of Crowdstrike/Sentinel One, in comparison DARK looked undervalued even at the top end.
A few of us have been LTH here since post IPO, a couple of traders too, but unfortunately there's also a lot of trolls with their own agendas posting now. Wise to verify anything said and DYOR always. GL.
ValueHunteress, The company is in a massive R&D phase currently. Working on closing the loop in cybersecurity, by building in self-healing mechanisms. That would save companies a huge whack of sales/time/human analysis. According to the Berenberg/Jefferies the house brokers who've seen examples, hugely impressive. The cost of this will apparently be kept fairly low as it builts on top of the software architecture previously developed.
DARK have said they're also looking at developing privacy tools, presumably at quite a high spec, ie to protect IP and critical information being exchanged.
From the facts at hand, my thinking is the behind-the-scenes old politics behind DARK's formation are largely responsible for the continuing volatility. For example:
Peel Hunt anaylysts were involved in the HP vs Autonomy case and have bad history with Mike Lynch.
Vanessa Colomar, the director who just sold half of her personal holding in DARK, was also involved in Autonomy/HP and is a partner alongside ML at Invoke Capital. As an experienced expert in PR and an investment partner at Invoke, it's inconceivable she's unaware what would happen to the SP! In addition her sells were bound to have a significant effect on the current value of her remaining large shareholding, alongside Invoke's and her partner ML's remaining holdings! So on the surface of it, cutting off her nose to spite her face, but as she's clearly a highly intelligent woman, that's doubtful.
Has her sale been timed to intentionally suppress the SP temporarily? Pure conjecture, but with Patel's extradition decision looming, can't help wonder if it's related to some accounting need, especially if she's privy to knowledge that will ensure a significant SP rise in the near future?
The other possibilities I can think of are that DARK Management has upset her, or she really needs the money (both appear unlikely given the background info tbh).
It's exasperating, but it doesn't change the very strong investment case. Great management, great inimitable products, huge potential market need, a tiny number of companies capable of producing this top-level of self-learning AI cybersec.
All imho, DYOR as always.
https://www.invokecapital.com/team
https://www.ibtimes.co.uk/creating-darktrace-british-tech-unicorn-1693575
https://www.theregister.com/2021/11/12/autonomy_cfo_us_court/
Yes Charles, something that: `...summarises the Moat , and Competetiveness of their products and future products , size of market etc would be good too'.
There's your homework for tonight then, I look forward to reading.
Maybe one for geekier souls like me, but excellent to see DARK staff (Oakley Cox) writing articles in top security publications (again).
This is great industry PR, and also gives potential clients a good insight how Dark's technology works with OT (Operational Technology) as is often found in critical infrastructure. https://www.darkreading.com/dr-tech/ripping-off-the-blindfold-illuminating-ot-environments
You're welcome Didi. That's sensible, diversification is a must! For what it's worth, shares sometimes inexplicably fall on news, but gain days later when they're publicised in the media, the same happened with LUCE. All the things I've heard about Volex have been good and Shares Magazine rate them highly too. :-)
RIP all the fallen. I've been doing our family history for some years and it really brings to life what huge sacrifices were made for us. So many young lives lost.
Please don't invest in companies that are involved in war or cause suffering to others.
Hi Didi, I can only give you my thoughts as a LTH, HKK, Mando or Claire are a better source for short-term price predictions. I'm hoping things remain quiet now until there's direct news from the company, that way I believe the SP will continue to steadily rise again. The AGM is on the 24th so let's see what that brings. I do think we're very undervalued here now, taking into account all broker forecasts, potential, sales and sales retention hints etc. That in itself will attract a lot of interest - especially from abroad while Sterling is low - but the volatility of recent weeks will also be putting some investors off.
On the whole I try to avoid focusing on the day-to-day movements of the SP, as that's led to making wrong moves in the past. That's more a thing to worry about if you're trading this or trying to add (which I did yesterday). GL. :-)
Nidec, I largely agree with your points,it just wasn't clear who you were addressing with your post when you said: `I don't understand why so many here believe every word Berenburg and Jeffries say while ****ging-off Peel Hunt.'
I didn't take it as a personal dig btw, but it appeared to be directed at other LTH more than traders.
Nidec, PH have a highly negative past history with Autonomy/ML (on record, you can do a search). As I understand it, they only accounted for one income stream of out of a potential five, including the Cloud - a potentially huge income stream, thanks to the collaboration/partnerships with Microsoft and AWS - which led DARK to issue a rebuttal.
Furthermore, the PH analyst also discounted DARK's technology as easily replicated, which it's absolutely not. We're talking a complex architecture of top-level Baysenian self-learning AI that's taken years of top-level software engineering to build and hone.
Berenburg/Jefferies have provided fairly good reasons for their more optimistic forecasts, including examples they've been shown of the R&D, high client retention/sales and information gleaned from Byte. This view was also backed up by Lending's earlier quote from the recent Buffetology Fund fact sheet, which I hope he won't mind me reposting here:
`As regards to Darktrace where aspersions have been cast about the quality of its R&D and product offering. I leave you with this thought. Bytes Technology is a software and hardware reseller... On its results call at the end of the month the CEO said, “ I know Darktrace has been in the press recently, but every single one of our Darktrace customers is renewing and customer satisfaction is very high.“ Bytes is Darktrace’s EMA partner of the Year so that’s a material sample size of customers he is talking about. This type of price action is precisely the sort of stock market noise that I always counsel against listening to. I do so again.'
I can only speak for myself, not others, but I try to assess these things for myself based on the evidence at hand and the wiser heads around. We all need to be aware of the `bias' of individual viewpoints, which is why the research/facts are so damned important.